Role of modifiable factors on the risk of colorectal and prostate cancer outcomes; the early detection of cancers through both established and new modalities; and the translation of population-based research into prevention strategies and clinically useful tools. ...read more
Learn more about clinical trials at Johns Hopkins Medicine.
Joshu CE, Peskoe SB, Heaphy CM, Kenfield SA, Van Blarigan EL, Mucci LA, Giovannucci E, Stampfer MJ, Yun GS, Lee T, Hicks JL, De Marzo AM, Meeker AK, Platz EA. Pre-diagnostic obesity and inactivity are associated with shorter telomere length in prostate stromal cells. Cancer Prev Res. 2015. Cancer Prev Res. 8(8):737-42 PMC4526348
Han X, Stevens J, Truesdale KP, Bradshaw PT, Kucharska-Newton A, Prizment AE, Platz EA, Joshu CE. Body mass index at early adulthood, subsequent weight change, and cancer incidence and mortality. 2014. International Journal of Cancer. 135(12):2900-9. PMC4192093
Joshu CE, Parmigiani G, Colditz GA, Platz EA. Opportunities for the primary prevention of colorectal cancer in the United States. 2012. Cancer Prev Res. 5(1):138-45. PMC3252472
Joshu CE, Mondul AM, Meinhold C, Humphreys EB, Han M, Walsh PC, Platz EA. Cigarette smoking and prostate cancer recurrence after prostatectomy. 2011. Journal of the National Cancer Institute 103(10):835-8. PMC3096800
Joshu CE, Mondul AM, Menke A, Meinhold C, Humphreys EB, Han M, Freedland SJ, Walsh PC, Platz EA. Weight gain is associated with an increased risk of prostate cancer recurrence after prostatectomy in the PSA era. 2011. Cancer Prevention Research 4(4):544-51. PMC3072036